HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Claudia Hube-Magg Selected Research

1-Acylglycerophosphocholine O-Acyltransferase (1 Acylglycerophosphocholine O Acyltransferase)

10/2021Increased lysophosphatidylcholine acyltransferase 1 expression is unrelated to prognosis of esophageal cancer patients.
1/2019Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancer.
12/2013High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Claudia Hube-Magg Research Topics

Disease

77Neoplasms (Cancer)
08/2022 - 11/2013
58Prostatic Neoplasms (Prostate Cancer)
06/2021 - 10/2013
9Carcinoma (Carcinomatosis)
01/2022 - 01/2020
9Lymphatic Metastasis
06/2021 - 09/2017
8Breast Neoplasms (Breast Cancer)
02/2022 - 01/2018
7Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 12/2018
6Microsatellite Instability
01/2022 - 01/2020
6Margins of Excision
06/2020 - 01/2014
5Genomic Instability
01/2021 - 01/2017
57 Hereditary Prostate Cancer
07/2020 - 05/2017
4Neoplasm Metastasis (Metastasis)
01/2022 - 12/2019
3Adenocarcinoma
02/2022 - 06/2020
3Colorectal Neoplasms (Colorectal Cancer)
02/2022 - 06/2021
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2022 - 06/2020
3Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 10/2020
2Acinar Cell Carcinoma
01/2022 - 01/2022
2Stomach Neoplasms (Stomach Cancer)
01/2022 - 12/2018
2Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
11/2021 - 06/2021
2Carcinogenesis
10/2021 - 01/2015
2Anaplastic Thyroid Carcinoma
10/2021 - 06/2021
2Esophageal Neoplasms (Esophageal Cancer)
10/2021 - 04/2019
2Papillary Carcinoma
03/2021 - 01/2020
2Hodgkin Disease (Hodgkin's Disease)
06/2020 - 12/2018
1Mesothelioma
02/2022
1Triple Negative Breast Neoplasms
01/2022
1Colonic Neoplasms (Colon Cancer)
01/2022
1Pancreatitis
01/2022
1Pleomorphic Adenoma
12/2021
1Teratoma (Teratoid Tumor)
12/2021
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
12/2021
1Papillomavirus Infections
12/2021
1Unknown Primary Neoplasms
10/2021
1Thyroid Neoplasms (Thyroid Cancer)
10/2021
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
10/2021
1Chondrosarcoma
10/2021
1Merkel Cell Carcinoma
06/2021
1Lobular Carcinoma
06/2021
1renal Oncocytoma
03/2021
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
06/2020
1Melanoma (Melanoma, Malignant)
06/2020
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2020

Drug/Important Bio-Agent (IBA)

34Proteins (Proteins, Gene)FDA Link
08/2022 - 03/2014
19Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2013
9Immune Checkpoint InhibitorsIBA
12/2021 - 08/2019
9Prostate-Specific Antigen (Semenogelase)IBA
01/2021 - 01/2014
6Androgen Receptors (Androgen Receptor)IBA
12/2019 - 05/2015
5AntibodiesIBA
02/2022 - 12/2018
5Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2020 - 04/2015
4Estrogen ReceptorsIBA
02/2022 - 12/2019
4DNA (Deoxyribonucleic Acid)IBA
03/2021 - 01/2017
3Progesterone Receptors (Progesterone Receptor)IBA
02/2022 - 12/2019
31-Acylglycerophosphocholine O-Acyltransferase (1 Acylglycerophosphocholine O Acyltransferase)IBA
10/2021 - 12/2013
3Transcription Factors (Transcription Factor)IBA
01/2021 - 11/2018
3Biological ProductsIBA
01/2020 - 10/2013
3TensinsIBA
01/2020 - 04/2015
3Serine Proteases (Serine Protease)IBA
01/2020 - 04/2015
2Immunoconjugates (Immunoconjugate)IBA
01/2022 - 01/2020
2Enhancer of Zeste Homolog 2 ProteinIBA
02/2021 - 11/2015
2Syndecan-1 (Syndecan 1)IBA
12/2019 - 01/2019
2Monoclonal AntibodiesIBA
12/2019 - 01/2019
2Cytotoxins (Cytolysins)IBA
12/2019 - 01/2019
2taxaneIBA
03/2019 - 10/2017
2TubulinIBA
12/2018 - 10/2017
2Y-Box-Binding Protein 1IBA
08/2018 - 01/2017
2Messenger RNA (mRNA)IBA
09/2017 - 05/2017
2RNA (Ribonucleic Acid)IBA
05/2017 - 01/2017
2Metalloproteases (Metalloproteinases)IBA
01/2017 - 10/2013
2Histones (Histone)IBA
11/2015 - 06/2015
2Phenobarbital (Luminal)FDA Link
01/2015 - 01/2015
1MucinsIBA
01/2022
1Surface Antigens (Surface Antigen)IBA
01/2022
1sacituzumab govitecanIBA
01/2022
1Keratin-7 (Cytokeratin 7)IBA
01/2022
1Keratin-20 (Cytokeratin 20)IBA
01/2022
1Mucin 5ACIBA
01/2022
1AS 8IBA
01/2022
1Carboxypeptidases A (Carboxypeptidase A)IBA
01/2022
1ArginaseIBA
12/2021
1Bicarbonates (Hydrogen Carbonate)IBA
12/2021
1CalciumIBA
12/2021
1ChloridesIBA
12/2021
1placental alkaline phosphataseIBA
11/2021
1ThyroglobulinFDA Link
10/2021
1Glycoproteins (Glycoprotein)IBA
10/2021
1Colloids (Colloid)IBA
10/2021
1Cadherins (E-Cadherin)IBA
06/2021
1MesothelinIBA
04/2021
1Polycomb Repressive Complex 2IBA
02/2021
1Keratin-19 (Keratin 19)IBA
01/2021
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2021
1Keratin-18 (Keratin 18)IBA
01/2021
1AnoctaminsIBA
01/2021
1Keratins (Keratin)IBA
01/2021
1Nuclear Proteins (Protein, Nuclear)IBA
12/2020
1Heterogeneous Nuclear Ribonucleoprotein A1IBA
11/2020
1Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA
11/2020
1WD repeat containing planar cell polarity effectorIBA
10/2020
1Claudin-1IBA
09/2020

Therapy/Procedure

13Therapeutics
12/2021 - 04/2015
7Prostatectomy (Retropubic Prostatectomy)
01/2019 - 10/2013